• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中的可变剪接与 RNA 疗法的前景。

Alternative splicing in neurodegenerative disease and the promise of RNA therapies.

机构信息

Neuroscience Graduate Program, University of California, Riverside, Riverside, CA, USA.

Center for RNA Biology and Medicine, University of California, Riverside, Riverside, CA, USA.

出版信息

Nat Rev Neurosci. 2023 Aug;24(8):457-473. doi: 10.1038/s41583-023-00717-6. Epub 2023 Jun 19.

DOI:10.1038/s41583-023-00717-6
PMID:37336982
Abstract

Alternative splicing generates a myriad of RNA products and protein isoforms of different functions from a single gene. Dysregulated alternative splicing has emerged as a new mechanism broadly implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer disease, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson disease and repeat expansion diseases. Understanding the mechanisms and functional outcomes of abnormal splicing in neurological disorders is vital in developing effective therapies to treat mis-splicing pathology. In this Review, we discuss emerging research and evidence of the roles of alternative splicing defects in major neurodegenerative diseases and summarize the latest advances in RNA-based therapeutic strategies to target these disorders.

摘要

选择性剪接可从单个基因生成具有不同功能的大量 RNA 产物和蛋白质异构体。失调的选择性剪接已成为一种新的机制,广泛涉及阿尔茨海默病、肌萎缩侧索硬化症、额颞叶痴呆、帕金森病和重复扩展疾病等神经退行性疾病的发病机制。了解神经紊乱中异常剪接的机制和功能结果对于开发治疗异常剪接病理的有效疗法至关重要。在这篇综述中,我们讨论了选择性剪接缺陷在主要神经退行性疾病中的作用的新研究和证据,并总结了针对这些疾病的基于 RNA 的治疗策略的最新进展。

相似文献

1
Alternative splicing in neurodegenerative disease and the promise of RNA therapies.神经退行性疾病中的可变剪接与 RNA 疗法的前景。
Nat Rev Neurosci. 2023 Aug;24(8):457-473. doi: 10.1038/s41583-023-00717-6. Epub 2023 Jun 19.
2
The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.疾病相关的 C9orf72 基因 r(GGGGCC)n 重复序列形成了依赖于片段长度的单分子和多分子 RNA G-四链体结构。
J Biol Chem. 2013 Apr 5;288(14):9860-9866. doi: 10.1074/jbc.C113.452532. Epub 2013 Feb 19.
3
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.额颞叶痴呆和肌萎缩侧索硬化的生物标志物发现与开发
Brain. 2022 Jun 3;145(5):1598-1609. doi: 10.1093/brain/awac077.
4
Tau Isoforms: Gaining Insight into Alternative Splicing.tau蛋白异构体:深入了解可变剪接
Int J Mol Sci. 2022 Dec 6;23(23):15383. doi: 10.3390/ijms232315383.
5
Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.RNA结合蛋白与微小RNA在神经退行性疾病中的相互作用
Int J Mol Sci. 2021 May 18;22(10):5292. doi: 10.3390/ijms22105292.
6
C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?C9orf72 相关的肌萎缩侧索硬化症和额颞叶痴呆:功能获得还是功能丧失?
Curr Opin Neurol. 2014 Oct;27(5):515-23. doi: 10.1097/WCO.0000000000000130.
7
Tau mis-splicing in the pathogenesis of neurodegenerative disorders.tau蛋白异常剪接在神经退行性疾病发病机制中的作用
BMB Rep. 2016 Aug;49(8):405-13. doi: 10.5483/bmbrep.2016.49.8.084.
8
Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.神经退行性疾病:剪接缺陷的温床和潜在的治疗方法。
Transl Neurodegener. 2021 May 20;10(1):16. doi: 10.1186/s40035-021-00240-7.
9
Cryptic inclusions UNCover losses driving neurodegeneration.隐秘内含物揭示导致神经退行性变的丧失。
Trends Genet. 2022 Sep;38(9):889-891. doi: 10.1016/j.tig.2022.06.004. Epub 2022 Jun 27.
10
RNA toxicity in non-coding repeat expansion disorders.非编码重复扩展障碍中的 RNA 毒性。
EMBO J. 2020 Jan 2;39(1):e101112. doi: 10.15252/embj.2018101112. Epub 2019 Nov 13.

引用本文的文献

1
Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson's Disease Mutations.携带家族性帕金森病突变的中脑谱系细胞中的可变前体mRNA剪接和基因表达模式
bioRxiv. 2025 Sep 4:2024.02.28.582420. doi: 10.1101/2024.02.28.582420.
2
Transcriptome Combined with Mendelian Randomization to Identify and Validate Biomarkers Associated with Parthanatos in Sepsis.转录组联合孟德尔随机化以鉴定和验证脓毒症中与PARP-1依赖性坏死相关的生物标志物
J Inflamm Res. 2025 Aug 15;18:11155-11176. doi: 10.2147/JIR.S532066. eCollection 2025.
3
MALAT1 regulates mRNA processing through sequence dependent RNA-RNA and RNA-protein interactions.

本文引用的文献

1
Multilayered regulations of alternative splicing, NMD, and protein stability control temporal induction and tissue-specific expression of TRIM46 during axon formation.多层次的剪接调控、NMD 和蛋白质稳定性控制了 TRIM46 在轴突形成过程中的时间诱导和组织特异性表达。
Nat Commun. 2022 Apr 19;13(1):2081. doi: 10.1038/s41467-022-29786-4.
2
Tauopathies: new perspectives and challenges.tau 病:新视角与新挑战。
Mol Neurodegener. 2022 Apr 7;17(1):28. doi: 10.1186/s13024-022-00533-z.
3
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.
MALAT1通过序列依赖性的RNA-RNA和RNA-蛋白质相互作用来调节mRNA加工。
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf784.
4
SPAT inhibits LUAD metastasis by targeting SF1-mediated splicing.SPAT通过靶向SF1介导的剪接抑制肺腺癌转移。
Cell Death Dis. 2025 Aug 8;16(1):598. doi: 10.1038/s41419-025-07924-2.
5
Long-read RNA-sequencing reveals transcript-specific regulation in human-derived cortical neurons.长读长RNA测序揭示了人源皮质神经元中特定转录本的调控机制。
Open Biol. 2025 Jul;15(7):250200. doi: 10.1098/rsob.250200. Epub 2025 Jul 30.
6
Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons.大规模RNA测序挖掘揭示环吡酮胺诱导TDP-43隐匿外显子。
Nat Commun. 2025 Jul 25;16(1):6878. doi: 10.1038/s41467-025-62004-5.
7
RNA chemistry and therapeutics.RNA化学与治疗学。
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01237-x.
8
Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's disease.对患有阿尔茨海默病的人类衰老大脑中RNA编辑景观的全面表征。
Alzheimers Dement. 2025 Jul;21(7):e70452. doi: 10.1002/alz.70452.
9
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.颅咽管瘤中剪接机制受损揭示PRPF8和RAVER1作为新型生物标志物和治疗靶点。
Acta Neuropathol Commun. 2025 Jun 28;13(1):142. doi: 10.1186/s40478-025-02040-w.
10
Amyloid formation of alternatively spliced variants of α-synuclein.α-突触核蛋白可变剪接变体的淀粉样蛋白形成
Protein Sci. 2025 Jul;34(7):e70195. doi: 10.1002/pro.70195.
一种可口服、可穿透血脑屏障的小分子通过增强假外显子的包含来降低亨廷顿蛋白水平。
Nat Commun. 2022 Mar 3;13(1):1150. doi: 10.1038/s41467-022-28653-6.
4
Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease.转录组与行为的综合分析确定了亨廷顿舞蹈病中依赖于亨廷顿蛋白(HTT)重复序列的网络模块。
Genes Dis. 2021 Jun 9;9(2):479-493. doi: 10.1016/j.gendis.2021.05.004. eCollection 2022 Mar.
5
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.TDP-43 缺失和 ALS 风险 SNPs 导致 UNC13A 的剪接错误和耗竭。
Nature. 2022 Mar;603(7899):131-137. doi: 10.1038/s41586-022-04436-3. Epub 2022 Feb 23.
6
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.TDP-43 抑制 FTD-ALS 基因 UNC13A 中的内含子剪接。
Nature. 2022 Mar;603(7899):124-130. doi: 10.1038/s41586-022-04424-7. Epub 2022 Feb 23.
7
Single molecule, long-read Apoer2 sequencing identifies conserved and species-specific splicing patterns.单分子、长读长 Apoer2 测序鉴定出保守和种属特异性的剪接模式。
Genomics. 2022 Mar;114(2):110318. doi: 10.1016/j.ygeno.2022.110318. Epub 2022 Feb 19.
8
A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease.帕金森病患者的 mRNA 和长链非编码 RNA 的转录组分析。
Int J Mol Sci. 2022 Jan 28;23(3):1535. doi: 10.3390/ijms23031535.
9
Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.不间断的 CAG 重复驱动人类亨廷顿 BAC 小鼠纹状体选择性转录病和核发病。
Neuron. 2022 Apr 6;110(7):1173-1192.e7. doi: 10.1016/j.neuron.2022.01.006. Epub 2022 Feb 2.
10
Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.反义寡核苷酸沉默 FUS 表达作为肌萎缩侧索硬化症的治疗方法。
Nat Med. 2022 Jan;28(1):104-116. doi: 10.1038/s41591-021-01615-z. Epub 2022 Jan 24.